ZEGALOGUE was evaluated across 3 clinical trials

STUDIES INCLUDED ADULTS, ADOLESCENTS, AND CHILDREN

ZEGALOGUE was studied in a clinical trial program of people with type 1 diabetes. Two trials were conducted in adults, and a third trial was conducted in children and adolescents aged 6 to 17 years. In all 3 trials, the results of participants who received ZEGALOGUE were compared with the results of those who received a placebo following insulin-induced low blood sugar. 

The primary goal in all 3 trials was to measure the time to blood sugar recovery, defined as an increase in blood sugar of at least 20 mg/dL from the time of administration, without additional intervention. 

ZEGALOGUE provided consistent results when needed

RAPID RECOVERY

In clinical trials, median time to blood sugar recovery was 10 minutes in adults, adolescents, and children.

BLOOD SUGAR RECOVERY IN A TRIAL OF ADULTS

99%

of adults recovered in 15 minutes

Reliable results: adults studied recovered with a single dose

In another trial, 88% of adult patients recovered in 15 minutes.

BLOOD SUGAR RECOVERY IN A TRIAL OF CHILDREN AND ADOLESCENTS

95%

of children and adolescents recovered in 15 minutes

Reliable results: children and adolescents studied recovered with a single dose

Most common side effects

In clinical trials, the most common side effects of ZEGALOGUE in adults were: 

  • Nausea
  • Vomiting
  • Headache
  • Diarrhea
  • Injection site pain

In clinical trials, the most common side effects of ZEGALOGUE in children and adolescents were: 

  • Nausea
  • Vomiting
  • Headache
  • Injection site pain 

For very low blood sugar, you can rely on ZEGALOGUE

Learn how you can be ready to treat very low blood sugar


Continue
Continue